A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model

NCT01965600 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06282999
DRUG: Placebo
OTHER: LPS
DRUG: PF-06282999
DRUG: Placebo
OTHER: LPS

Sponsor

Pfizer